{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:33:54Z","timestamp":1776332034795,"version":"3.50.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221750","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T17:28:23Z","timestamp":1567099703000},"page":"e0221750","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-2983","authenticated-orcid":true,"given":"Amelia Nur","family":"Vidyanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Y.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-5967","authenticated-orcid":true,"given":"Chaur-Jong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"issue":"2","key":"pone.0221750.ref001","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.STR.25.2.333","article-title":"Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project","volume":"25","author":"J Burn","year":"1994","journal-title":"Stroke"},{"issue":"12","key":"pone.0221750.ref002","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/01.STR.29.12.2491","article-title":"Long-term risk of first recurrent stroke in the Perth Community Stroke Study","volume":"29","author":"GJ Hankey","year":"1998","journal-title":"Stroke"},{"issue":"7","key":"pone.0221750.ref003","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"WN Kernan","year":"2014","journal-title":"Stroke"},{"issue":"7","key":"pone.0221750.ref004","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/STROKEAHA.118.024497","article-title":"Antiplatelet Therapy After Noncardioembolic Stroke","volume":"50","author":"JP Greving","year":"2019","journal-title":"Stroke"},{"issue":"4","key":"pone.0221750.ref005","first-page":"Cd001246","article-title":"Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"CL Sudlow","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"9038","key":"pone.0221750.ref006","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"The Lancet"},{"issue":"6","key":"pone.0221750.ref007","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0002-9343(99)00295-8","article-title":"Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events","volume":"107","author":"JJ Caro","year":"1999","journal-title":"The American journal of medicine"},{"issue":"8","key":"pone.0221750.ref008","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/STROKEAHA.109.551812","article-title":"Patients enrolled in large randomized clinical trials of antiplatelet treatment for prevention after transient ischemic attack or ischemic stroke are not representative of patients in clinical practice: the Netherlands Stroke Survey","volume":"40","author":"L Maasland","year":"2009","journal-title":"Stroke"},{"issue":"9","key":"pone.0221750.ref009","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"MH Criqui","year":"2015","journal-title":"Circulation research"},{"key":"pone.0221750.ref010","article-title":"The relationship between stasis-stagnation constitution and peripheral arterial disease in patients with type 2 diabetes","volume":"2014","author":"K-C Huang","year":"2014","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"issue":"2","key":"pone.0221750.ref011","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1586\/ern.10.203","article-title":"Antiplatelet resistance in stroke","volume":"11","author":"MA Top\u00e7uoglu","year":"2011","journal-title":"Expert review of neurotherapeutics"},{"issue":"4","key":"pone.0221750.ref012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ane.12111","article-title":"Clinical consequences of aspirin and clopidogrel resistance: an overview","volume":"128","author":"M Mijajlovic","year":"2013","journal-title":"Acta Neurologica Scandinavica"},{"issue":"12","key":"pone.0221750.ref013","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00003088-200241120-00002","article-title":"Clinical significance of the cytochrome P450 2C19 genetic polymorphism","volume":"41","author":"Z Desta","year":"2002","journal-title":"Clinical pharmacokinetics"},{"issue":"4","key":"pone.0221750.ref014","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"JL Mega","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0221750.ref015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Y Wang","year":"2016","journal-title":"Jama"},{"issue":"1","key":"pone.0221750.ref016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Y Pan","year":"2017","journal-title":"Circulation"},{"key":"pone.0221750.ref017","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2017.03.010","article-title":"High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis","volume":"376","author":"A Fiolaki","year":"2017","journal-title":"Journal of the neurological sciences"},{"issue":"1\u20132","key":"pone.0221750.ref018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1006934612368","article-title":"Antioxidant properties of aspirin: characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-\u03baB activation, and TNF-\u03b1 production","volume":"199","author":"X Shi","year":"1999","journal-title":"Molecular and cellular biochemistry"},{"issue":"Supplement 1","key":"pone.0221750.ref019","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.2337\/dc18-S009","article-title":"Cardiovascular disease and risk management: standards of medical care in diabetes\u20142018","volume":"41","author":"AD Association","year":"2018","journal-title":"Diabetes care"},{"issue":"9","key":"pone.0221750.ref020","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/STROKEAHA.117.017895","article-title":"Antiplatelet regimen for patients with breakthrough strokes while on aspirin: a systematic review and meta-analysis","volume":"48","author":"M Lee","year":"2017","journal-title":"Stroke"},{"issue":"4","key":"pone.0221750.ref021","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1747-4949.2010.00443.x","article-title":"A critical review of aspirin in the secondary prevention of noncardioembolic ischaemic stroke","volume":"5","author":"D Inzitari","year":"2010","journal-title":"International Journal of Stroke"},{"issue":"12","key":"pone.0221750.ref022","doi-asserted-by":"crossref","first-page":"e006672","DOI":"10.1136\/bmjopen-2014-006672","article-title":"Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study","volume":"4","author":"M Lee","year":"2014","journal-title":"Bmj Open"},{"issue":"19","key":"pone.0221750.ref023","doi-asserted-by":"crossref","first-page":"e009856","DOI":"10.1161\/JAHA.118.009856","article-title":"Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real\u2010World Data","volume":"7","author":"NF Chi","year":"2018","journal-title":"Journal of the American Heart Association"},{"issue":"8","key":"pone.0221750.ref024","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjmed.2005.10.039","article-title":"Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials","volume":"119","author":"KR McQuaid","year":"2006","journal-title":"The American journal of medicine"},{"issue":"23","key":"pone.0221750.ref025","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence\u2014what is it and what can it tell us","volume":"375","author":"RE Sherman","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0221750.ref026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00019053-200422004-00005","article-title":"The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE study","volume":"22","author":"I Durand-Zaleski","year":"2004","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"pone.0221750.ref027","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/11535520-000000000-00000","article-title":"Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden","volume":"8","author":"JFS Logman","year":"2010","journal-title":"Applied health economics and health policy"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0232016","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T23:07:44Z","timestamp":1664233664000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221750"}},"subtitle":[],"editor":[{"given":"Aristeidis H.","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221750","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0232016","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]}}}